[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjrbaek C, Flier JS
Why Perfect B Is Evaluating AOD 9604: Our Clinical Perspective We began our internal evaluation of AOD 9604 in response to a consistent pattern we were seeing with patients in our South Florida practice: people who had experienced meaningful fat loss on GLP-1 medications, then plateaued or discontinued due to side effects, and were looking for a next option
**The FDA does not review or approve any compounded medications for safety or effectiveness
By reducing stress and enhancing overall well-being, it also encourages you to stay committed to your weight loss routine
NNMT inhibition increases NAD+ levels and enhances sirtuin-mediated mitochondrial function
AOD-9604 Protocol Mistakes & Troubleshooting 01 Missed dose If a daily dose is missed, the next dose can be taken at the normal time the following day